IMMUNE ONCIA THERAPEUTICS INC. Trademark

Trademark Overview


On Tuesday, December 31, 2024, a trademark application was filed for IMMUNE ONCIA THERAPEUTICS INC. with the United States Patent and Trademark Office. The USPTO has given the IMMUNE ONCIA THERAPEUTICS INC. trademark a serial number of 79422542. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 3, 2026. This trademark is owned by ImmuneOncia Therapeutics, Inc.. The IMMUNE ONCIA THERAPEUTICS INC. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; research and development of vaccines and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; medical research laboratory services; providing information on the testing, inspection and research of medical products; pharmaceutical product evaluation; engineering services in the medical technology; medical research; drug discovery services; research and development of new products for others; chemical laboratory services; biotechnology research; technical consultancy in relation to research services relating to foods and dietary supplements
immune oncia therapeutics inc.

General Information


Serial Number79422542
Word MarkIMMUNE ONCIA THERAPEUTICS INC.
Filing DateTuesday, December 31, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 3, 2026

Trademark Statements


NOT AVAILABLE"THERAPEUTICS INC."
Goods and ServicesScientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; research and development of vaccines and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; medical research laboratory services; providing information on the testing, inspection and research of medical products; pharmaceutical product evaluation; engineering services in the medical technology; medical research; drug discovery services; research and development of new products for others; chemical laboratory services; biotechnology research; technical consultancy in relation to research services relating to foods and dietary supplements
Pseudo MarkIMMUNE ONCIA THERAPEUTICS INC
Indication of Colors claimedThe colors Black, Blue, Sky-blue, and Gray are claimed as a feature of the mark.
Description of MarkThe mark consists of the stylized wording "IMMUNEONCIA THERAPEUTICS INC." with "IMMUNE" and "IA " in black, "ONC in blue and "THERAPEUTICS INC." in gray and a design of various circles in blue and sky-blue with one circle connecting to the "O" forming an amoeba-like shape.
Translation of Words in MarkThe English translation of "ONCIA" in the mark is "ounce".

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 24, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmuneOncia Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameImmuneOncia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, April 24, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, April 28, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 28, 2025APPLICATION FILING RECEIPT MAILED
Thursday, June 12, 2025ASSIGNED TO EXAMINER
Tuesday, June 17, 2025NON-FINAL ACTION WRITTEN
Wednesday, June 18, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 6, 2025REFUSAL PROCESSED BY MPU
Wednesday, August 6, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, August 23, 2025REFUSAL PROCESSED BY IB
Thursday, December 11, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 11, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 12, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 6, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 13, 2026NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 14, 2026NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 28, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 29, 2026NOTIFICATION PROCESSED BY IB
Tuesday, February 3, 2026PUBLISHED FOR OPPOSITION
Tuesday, February 3, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED